Page last updated: 2024-10-26

valproic acid and Eye Cancer, Retinoblastoma

valproic acid has been researched along with Eye Cancer, Retinoblastoma in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kawano, T1
Akiyama, M1
Agawa-Ohta, M1
Mikami-Terao, Y1
Iwase, S1
Yanagisawa, T1
Ida, H1
Agata, N1
Yamada, H1

Other Studies

1 other study available for valproic acid and Eye Cancer, Retinoblastoma

ArticleYear
Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation.
    International journal of oncology, 2010, Volume: 37, Issue:4

    Topics: Acetylation; Apoptosis; Caspase 3; Cell Cycle Proteins; Cell Line, Tumor; Depsipeptides; Dose-Respon

2010